Arterial Stiffness and Vascular Aging: A Brief Overview

Arterial stiffness is a hallmark of vascular aging and a major independent risk factor for cardiovascular diseases (CVD), including hypertension, stroke, and heart failure.

Mechanisms of Arterial Stiffening As humans age, the arterial wall undergoes profound structural and functional changes. The highly elastic elastin fibers degrade and fragment, while stiffer collagen fibers accumulate. This process can be heavily accelerated by cardiovascular risk factors like diabetes, smoking, and obesity, leading to a phenomenon known as "early vascular aging" (EVA). A key molecular driver of this stiffening is the formation of Advanced Glycation End-products (AGEs). AGEs create irreversible, non-enzymatic cross-links between collagen fibers, causing the vascular wall to lose its elasticity and become highly rigid.

Clinical Consequences Healthy, elastic arteries act as a cushion (the Windkessel effect) to buffer the pulsatile blood flow ejected from the heart. When arteries stiffen, this buffering capacity is lost, causing the pressure pulse to travel much faster along the arterial tree—a metric known as Pulse Wave Velocity (PWV). This leads to an increased systolic blood pressure and a widened pulse pressure. The heightened pulsatile energy damages the microvasculature of highly perfused organs, contributing to cognitive decline, chronic kidney disease, left ventricular hypertrophy, and heart failure with preserved ejection fraction (HFpEF).

Measurement and Prediction Carotid-femoral pulse wave velocity (cfPWV) is widely considered the non-invasive "gold standard" for measuring arterial stiffness and predicting future cardiovascular events. Recently, Artificial Intelligence (AI) models have also been developed to estimate "vascular age" (AI-VA) from simple, uncalibrated peripheral pressure waveforms, offering a highly scalable tool for early CVD risk screening.

Prevention and Treatment

• Lifestyle Modifications: Regular aerobic exercise, caloric restriction, and dietary changes (such as low sodium intake, and diets rich in omega-3 fatty acids and polyphenols) are primary strategies for preventing and mitigating arterial stiffness.
• Pharmacological Therapy: Standard antihypertensive medications, particularly renin-angiotensin-aldosterone system (RAAS) blockers, as well as statins and newer anti-diabetic drugs like SGLT2 inhibitors, have been shown to reduce arterial stiffness.
• Novel Therapies: Researchers have investigated "AGE-breakers," specifically Alagebrium (ALT-711), which chemically severs the cross-links between glycated collagen fibers. While Alagebrium showed promise in animal models and early human trials by reducing arterial and myocardial stiffness, its clinical development was ultimately discontinued due to financial limitations and mixed efficacy in larger trials.